On this page
Signal check
What changed—and what was not tested
Neither peptide changed the reported motor and defensive measures; the described reduction in anxiety was associated with Selank. This study should not be cited as proof that Semax improved all measured Parkinson-like outcomes.
Peptides semax and selank affect the behavior of rats with 6-OHDA induced PD-like parkinsonism. (2017)
- Measured signal
- Motor activity, defensive behavior and anxiety-related behavior.
- Design
- Peptide comparison after experimentally induced dopaminergic injury.
- Population or preparation
- Rats with a 6-hydroxydopamine-induced Parkinson-like model.
- Reported change
- Neither peptide changed the reported motor and defensive measures; the described reduction in anxiety was associated with Selank.
- Inference boundary
- This study should not be cited as proof that Semax improved all measured Parkinson-like outcomes.
The experimental design
Peptide comparison after experimentally induced dopaminergic injury.
Who or what was studied
Rats with a 6-hydroxydopamine-induced Parkinson-like model.
The measurement
Motor activity, defensive behavior and anxiety-related behavior. For a separate account of movement and anxiety-related behavior, read Semax in an MPTP model. For a separate account of after-discharges, seizure threshold and motor convulsions, read Semax seizure-model research.
The reported finding
Neither peptide changed the reported motor and defensive measures; the described reduction in anxiety was associated with Selank. A paper title naming two peptides does not mean every favorable finding applies to both. Attribution to the correct study arm is essential, particularly when a product combines the names in one package.
What the result cannot establish
This study should not be cited as proof that Semax improved all measured Parkinson-like outcomes. Ask which intervention produced the result being advertised and which measured outcomes did not improve. A selective title citation can hide both distinctions. The consultation checklist can help you ask which part of this experimental result matches the preparation and goal under discussion.
A related comparison
The MPTP behavioral guide examines a different toxin model with a different reported pattern. Neither model is a clinical trial in Parkinson disease.
Evidence index
Original research and documented service details.